anesthesia for children with congenital heart disease
DESCRIPTION
Presented at Egyptian Pediatric Anesthesia Conference held at Cairo, Egypt. www.egyptpac.orgTRANSCRIPT
![Page 1: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/1.jpg)
CHILDREN WITH
CONGENITAL
HEART DISEASEGeorge Nicolaou, MD FRCPC
Department of Anesthesia
& Perioperative Medicine
University of Western Ontario
ANESTHESIA FOR
![Page 2: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/2.jpg)
INTRODUCTION
• Number of children reaching adulthood with
CHD has increased over the last 5 decades
• D/T advances in diagnosis, medical, critical
and surgical care
• Therefore, not uncommon for adult patients
with CHD to present for non-cardiac surgery
![Page 3: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/3.jpg)
INCIDENCE
• 7 to 10 per 1000 live births
• Premature infants 2-3X higher incidence
• Most common form of congenital disease
• Accounts for 30% of total incidence of all congenital diseases
• 10% -15% have associated congenital anomalies of skeletal, RT, GUT or GIT
• Only 15% survive to adulthood without treatment
![Page 4: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/4.jpg)
ETIOLOGY
• 10% associated with chromosomal abnormalities
• Two thirds of these occur with Trisomy 21
• One third occur with karyotypic abnormalities such
as Trisomy 13, Trisomy 18 & Turner Syndrome
• Remaining 90% are multifactorial in origin
• Interaction of several genes with or without
external factors such as rubella, ethanol abuse,
lithium and maternal diabetes mellitus
![Page 5: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/5.jpg)
FETAL CIRCULATION
• There are 4 shunts in
fetal circulation:
placenta, ductus
venosus, foramen ovale,
and ductus arteriosus
• In adult, gas exchange
occurs in lungs. In fetus,
the placenta provides
the exchange of gases
and nutrients
![Page 6: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/6.jpg)
CARDIOPULMONARY CHANGES AT BIRTH
• Removal of placenta results in following:
• ↑ SVR (because the placenta has lowest
vascular resistance in the fetus)
• Cessation of blood flow in the umbilical vein
resulting in closure of the ductus venosus
![Page 7: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/7.jpg)
CARDIOPULMONARY CHANGES AT BIRTH
• Lung expansion →
reduction of the
pulmonary vascular
resistance (PVR), an
increase in pulmonary
blood flow, & a fall in
PA pressure
![Page 8: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/8.jpg)
CARDIOPULMONARY CHANGES AT BIRTH
• LUNG EXPANSION:
– Functional closure of the foramen ovale as a result
↑ LAP in excess RAP
– The LAP increases as a result of the ↑ PBF and ↑
pulmonary venous return to the LA
– RAP pressure falls as a result of closure of the
ductus venosus
– PDA closure D/T ↑ arterial oxygen saturation
![Page 9: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/9.jpg)
CARDIOPULMONARY CHANGES AT BIRTH
• PVR high as SVR near or at
term
• High PVR maintained by ↑
amount of smooth muscle in
walls of pulmonary
arterioles & alveolar
hypoxia resulting from
collapsed lungs
• Lung expansion → ↑
alveolar oxygen tension →
↓ PVR
![Page 10: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/10.jpg)
CLASSIFICATION OF CHD
• L – R SHUNTS
– Defects connecting arterial & venous circulation
– SVR > PVR → ↑ PBF
– ↑ pulmonary blood flow → pulmonary congestion
→ CHF → ↑ susceptibility to RTI
– Long standing L-R shunts → PHT
– PVR > SVR → R-L shunt → Eisenmenger’s
syndrome
![Page 11: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/11.jpg)
CLASSIFICATION OF CHD
• L - R SHUNTS INCLUDE :
– ASD →7.5% of CHD
– VSD → COMMONEST CHD – 25%
– PDA → 7.5% of CHD
• Common in premature infants
– ENDOCARDIAL CUSHION DEFECT - 3%
• Often seen with trisomy 21
– AORTOPULMONARY WINDOW
![Page 12: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/12.jpg)
VENTRICULAR SEPTAL DEFECT
![Page 13: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/13.jpg)
ATRIOVENTRICULAR CANAL DEFECT
![Page 14: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/14.jpg)
L – R SHUNTS
• PERIOPERATIVE TREATMENT
– Indomethacin → PDA closure
– Digoxin, diuretics, ACE inhibitors → CHF
– Main PA band → ↑ PVR → ↓ L-R shunt
– Definitive open heart surgery
• POSTOPERATIVE PROBLEMS
– SVTs and conduction delays
– Valvular incompetence → most common after
canal defect repairs
![Page 15: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/15.jpg)
CLASSIFICATION OF CHD
• R – L SHUNTS
– Defect between R and L heart
– Resistance to pulmonary blood flow → ↓ PBF →
hypoxemia and cyanosis
• INCLUDE :
– TOF – 10% of CHD, commonest R-L shunt
– PULMONARY ATRESIA
– TRICUSPID ATRESIA
– EBSTEIN’S ANOMALY
![Page 16: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/16.jpg)
R – L SHUNTS
• GOAL → ↑ PBF to improve oxygenation
– Neonatal PGE1 (0.03 – 0.10mcg/kg/min)
maintains PDA → ↑ PBF
– PGE1 complications → vasodilatation,
hypotension, bradycardia, arrhythmias, apnea or
hypoventilation, seizures, hyperthermia
– Palliative shunts → ↑ PBF, improve hypoxemia
and stimulate growth in PA → aids technical
feasibility of future repair
![Page 17: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/17.jpg)
GLENN SHUNT
![Page 18: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/18.jpg)
MODIFIED BLALOCK-TAUSSIG
SHUNT
![Page 19: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/19.jpg)
TETRALOGY OF FALLOT
• 10% of all CHD
• Most common R – L shunt
• 4 anomalies:
– RVOT obstruction ( infundibular, pulmonic or
supravalvular stenosis )
– Subaortic VSD
– Overriding aorta
– RVH
![Page 20: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/20.jpg)
TETRALOGY OF FALLOT
![Page 21: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/21.jpg)
TETRALOGY OF FALLOT
• Hypercyanotic ( “tet” ) spells occur D/T
infundibular spasm, low pH or low PaO2
• In awake patient manifests as acute cyanosis &
hyperventilation
• May occur with feeding, crying, defecation or
stress
• During anesthesia D/T acute dynamic
infundibular spasm
![Page 22: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/22.jpg)
TETRALOGY OF FALLOT
• Treatment of Hypercyanotic Spells
– High FiO2 → pulmonary vasodilator → ↓ PVR
– Hydration (fluid bolus) → opens RVOT
– Morphine (0.1mg/kg/dose) → sedation,↓ PVR
– Ketamine → ↑ SVR, sedation, analgesia → ↑ PBF
– Phenylephrine (1mcg/kg/dose) → ↑ SVR
– β-blockers (Esmolol 100-200mcg/kg/min)
→ ↓HR,-ve inotropy → improves flow across
obstructed valve &↓ infundibular spasm
![Page 23: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/23.jpg)
TETRALOGY OF FALLOT
• Halothane → ↓ HR & -ve inotropy
– Rapidly tuned on and off
– Careful in severe RVF
• Thiopental → -ve inotropy
• Squatting, abdominal compression→↑ SVR
![Page 24: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/24.jpg)
EBSTEIN’S ANOMALY
![Page 25: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/25.jpg)
CLASSIFICATION OF CHD
• COMPLEX SHUNTS (MIXING LESIONS)
– Continuous mixing of venous and arterial blood –
blood saturation 70% - 80%
– May or may not be obstruction to flow
– Produce both cyanosis and CHF
– Overzealous improvement in PBF steals
circulation from aorta → systemic hypotension →
coronary ischemia
![Page 26: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/26.jpg)
CLASSIFICATION OF CHD
• COMPLEX SHUNTS INCLUDE :
– TRUNCUS ARTERIOSUS
– TRANSPOSITION OF GREAT VESSELS – 5%
• Arterial switch procedure > 95% survival
– TOTAL ANOMALOUS PV RETURN
– DOUBLE OUTLET RIGHT VENTRICLE
– HYPOPLASTIC LEFT HEART SYNDROME
• Most common CHD presenting 1st week of life
• Most common cause of death in 1st month of life
![Page 27: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/27.jpg)
TOTAL ANOMALOUS PULMONARY
VENOUS RETURN
![Page 28: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/28.jpg)
TOTAL ANOMALOUS PULMONARY
VENOUS RETURN
![Page 29: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/29.jpg)
HYPOPLASTIC LEFT HEART SYNDROME
![Page 30: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/30.jpg)
TRANSPOSITION OF GREAT VESSELS
![Page 31: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/31.jpg)
TRUNCUS ARTERIOSUS
![Page 32: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/32.jpg)
DOUBLE OUTLET RIGHT VENTRICLE
![Page 33: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/33.jpg)
FONTAN PROCEDURE
![Page 34: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/34.jpg)
NORWOOD PROCEDURE
![Page 35: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/35.jpg)
JATENE PROCEDURE
![Page 36: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/36.jpg)
CLASSIFICATION OF CHD
• OBSTRUCTIVE LESIONS
– Either valvular stenosis or vascular bands
– ↓ perfusion & pressure overload of corresponding ventricle
– CHF common
– Right sided obstructions PBF hypoxemia and cyanosis
– Left sided obstructions systemic blood flow tissue hypoperfusion, metabolic acidosis and shock
![Page 37: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/37.jpg)
CLASSIFICATION OF CHD
• OBSTRUCTIVE LESIONS INCLUDE :
– AORTIC STENOSIS
– MITRAL STENOSIS
– PULMONIC STENOSIS
– COARCTATION OF AORTA – 8% of CHD
• 80% have bicuspid aortic valve
– COR TRIATRIATUM
– INTERRUPTED AORTIC ARCH
![Page 38: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/38.jpg)
COARCTATION OF AORTA
![Page 39: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/39.jpg)
COARCTATION OF AORTA
![Page 40: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/40.jpg)
INTERUPTION OF AORTIC ARCH
![Page 41: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/41.jpg)
COR TRIATIATUM
![Page 42: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/42.jpg)
CLASSIFICATION OF CHD
![Page 43: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/43.jpg)
CLASSIFICATION OF CHD
![Page 44: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/44.jpg)
ANESTHETIC MANAGEMENT
• Perioperative management requires a team
approach
• Most important consideration is necessity for
individualized care
• CHD is polymorphic and may clinically
manifest across a broad clinical spectrum
![Page 45: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/45.jpg)
ANESTHETIC MANAGEMENT
• Unpalliated
• Partially palliated
• Completely palliated
– ASD and PDA only congenital lesions that
can be truly “corrected”
Anesthesiologists will encounter children with
CHD for elective non-cardiac surgery at one of
three stages:
![Page 46: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/46.jpg)
ANESTHETIC MANAGEMENT
• 50% Dx by 1st week of life; rest by 5 years
• Child’s diagnosis & current medical condition will determine preoperative evaluation
• Understand the anatomic and hemodynamic function of child’s heart
• Discuss case with pediatrician and cardiologist
• Review diagnostic & therapeutic interventions
• Above will estimate disease severity and help formulate anesthetic plan
![Page 47: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/47.jpg)
HISTORY & PHYSICAL
• Assess functional status – daily activities & exercise tolerance
• Infants - ↓ cardiac reserve → cyanosis, diaphoresis & respiratory distress during feeding
• Palpitations, syncope, chest pain
• Heart murmur (s)
• Congestive heart failure
• Hypertension
![Page 48: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/48.jpg)
HISTORY & PHYSICAL
• Tachypnea, dyspnea, cyanosis
• Squatting
• Clubbing of digits
• FTT d/t limited cardiac output and increased
oxygen consumption
• Medications – diuretics, afterload reduction
agents, antiplatelet, anticoagulants
• Immunosuppressants – heart transplant
![Page 49: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/49.jpg)
LABORATORY EVALUATION
• BLOODWORK
• Electrolyte disturbances 2° to chronic diuretic therapy
or renal dysfunction
• Hemoglobin level best indicator of R-L shunting
magnitude & chronicity
• Hematocrit to evaluate severity of polycythemia or
iron deficiency anemia
• Screening coagulation tests
• Baseline ABG & pulse oximetry
• Calcium & glucose - newborns, critically ill children
![Page 50: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/50.jpg)
LABORATORY EVALUATION
• 12 LEAD EKG
– Chamber enlargement/hypertrophy
– Axis deviation
– Conduction defects
– Arrhythmias
– Myocardial ischemia
![Page 51: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/51.jpg)
LABORATORY EVALUATION
• CHEST X - RAY
– Heart size and shape
– Prominence of pulmonary vascularity
– Lateral film if previous cardiac surgery for
position of major vessels in relation to sternum
![Page 52: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/52.jpg)
LABORATORY EVALUATION
• ECHOCARDIOGRAPHY
– Anatomic defects/shunts
– Ventricular function
– Valve function
– Doppler & color flow imaging direction of
flow through defect/valves, velocities and
pressure gradients
![Page 53: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/53.jpg)
LABORATORY EVALUATION
• CARDIAC CATHERIZATION
– Size & location of defects
– Degree of stenosis & shunt
– Pressure gradients & O2 saturation in each
chamber and great vessel
– Mixed venous O2 saturation obtained in SVC or
proximal to area where shunt occurs
– Low saturations in LA and LV = R – L shunt
– High saturations in RA & RV = L – R shunt
![Page 54: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/54.jpg)
LABORATORY EVALUATION
• CARDIAC CATHERIZATION
– Determine shunt direction: ratio of pulmonary to
systemic blood flow : Qp / Qs
– Qp / Qs ratio < 1= R – L shunt
– Qp / Qs ratio > 1= L – R shunt
![Page 55: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/55.jpg)
PREMEDICATION
a) Omit for infants < six months of age
b) Administer under direct supervision of Anesthesiologist in preoperative facility
c) Oxygen, ventilation bag, mask and pulse oximetry immediately available
d) Oral Premedication
• Midazolam 0.25 -1.0 mg/kg
• Ketamine 2 - 4 mg/kg
• Atropine 0.02 mg/kg
![Page 56: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/56.jpg)
PREMEDICATION
e) IV Premedication
• Midazolam 0.02 - 0.05 mg/kg titrated in small
increments
f) IM Premedication
• Uncooperative or unable to take orally
• Ketamine 1-2 mg/kg
• Midazolam 0.2 mg/kg
• Glycopyrrolate or Atropine 0.02 mg/kg
![Page 57: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/57.jpg)
MONITORING
• Routine CAS monitoring
• Precordial or esophageal stethoscope
• Continuous airway manometry
• Multiple - site temperature measurement
• Volumetric urine collection
• Pulse oximetry on two different limbs
• TEE
![Page 58: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/58.jpg)
MONITORING
• PDA
– Pulse oximetry right hand to measure pre-ductal
oxygenation
– 2nd probe on toe to measure post-ductal
oxygenation
• COARCTATION OF AORTA
– Pulse oximeter on right upper limb
– Pre and post - coarctation blood pressure cuffs
should be placed
![Page 59: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/59.jpg)
ANESTHETIC AGENTS
• INHALATIONAL AGENTS
– Safe in children with minor cardiac defects
– Most common agents used are halothane and
sevoflurane in oxygen
– Monitor EKG for changes in P wave retrograde
P wave or junctional rhythm may indicate too deep
anesthesia
![Page 60: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/60.jpg)
INHALATIONAL ANESTHETICS
• HALOTHANE
– Depresses myocardial function, alters sinus
node function, sensitizes myocardium to
catecholamines
– MAP + HR
– CI + EF
• Relax infundibular spasm in TOF
• Agent of choice for HCOM
![Page 61: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/61.jpg)
INHALATIONAL ANESTHETICS
SEVOFLURANE
• No HR
• Less myocardial depression than Halothane
• Mild SVR → improves systemic flow in L-R
shunts
• Can produce diastolic dysfunction
![Page 62: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/62.jpg)
INHALATIONAL ANESTHETICS
ISOFLURANE
• Pungent not good for induction
• Incidence of laryngospasm > 20%
• Less myocardial depression than Halothane
• Vasodilatation leads to SVR → MAP
• HR which can lead to CI
![Page 63: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/63.jpg)
INHALATIONAL ANESTHETICS
DESFLURANE
• Pungent not good for induction; highest
incidence of laryngospasm
• SNS activation → with fentanyl
• HR + SVR
• Less myocardial depression than Halothane
![Page 64: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/64.jpg)
INHALATIONAL ANESTHETICS
NITROUS OXIDE
• Enlarge intravascular air emboli
• May cause microbubbles and macrobubbles to
expand obstruction to blood flow in
arteries and capillaries
• In shunts, potential for bubbles to be shunted
into systemic circulation
![Page 65: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/65.jpg)
INHALATIONAL ANESTHETICS
NITROUS OXIDE
• At 50% concentration does not affect PVR and
PAP in children
• Mildly CO at 50% concentration
• Avoid in children with limited pulmonary
blood flow, PHT or myocardial function
![Page 66: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/66.jpg)
IM & IV ANESTHETICS
KETAMINE
• No change in PVR in children when airway maintained & ventilation supported
• Sympathomimetic effects help maintain HR, SVR, MAP and contractility
• Greater hemodynamic stability in hypovolemic patients
• Copious secretions → laryngospasm → atropine or glycopyrrolate
![Page 67: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/67.jpg)
IM & IV ANESTHETICS
KETAMINE
• Relative contraindications may be coronary insufficiency caused by:
– anomalous coronary artery
– severe critical AS
– hypoplastic left heart syndrome with aortic atresia
– hypoplasia of the ascending aorta
• Above patients prone to VF d/t coronary insufficiency d/t catecholamine release from ketamine
![Page 68: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/68.jpg)
IM & IV ANESTHETICS
IM Induction with Ketamine:
• Ketamine 5 mg/kg
• Succinylcholine 5 mg/kg or Rocuronium 1.5 – 2.0 mg/kg
• Atropine or Glycopyrrolate 0.02 mg/kg
IV Induction with Ketamine:
• Ketamine 1-2 mg/kg
• Succinylcholine 1-2 mg/kg or Rocuronium 0.6-1.2 mg/kg
• Atropine or Glycopyrrolate 0.01 mg/kg
![Page 69: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/69.jpg)
IM & IV ANESTHETICS
OPIOIDS• Excellent induction agents in very sick children
• No cardiodepressant effects if bradycardia avoided
• If used with N2O - negative inotropic effects of
N2O may appear
• Fentanyl 25-100 µg/kg IV
• Sufentanil 5-20 µg/kg IV
• Pancuronium 0.05 - 0.1 mg/kg IV offset
vagotonic effects of high dose opioids
![Page 70: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/70.jpg)
IM & IV ANESTHETICS
ETOMIDATE• CV stability
• 0.3 mg/kg IV
THIOPENTAL & PROPOFOL• Not recommended in patients with severe cardiac
defects
• In moderate cardiac defects:– Thiopental 1-2 mg/kg IV or Propofol 1-1.5 mg/kg IV
– Patient euvolemic
![Page 71: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/71.jpg)
ANESTHETIC MANAGEMENT
• GENERAL PRINCIPLES
Where:
Q = Blood flow (CO)
P = Pressure within a chamber or vessel
R = Vascular resistance of pulmonary or
systemic vasculature
Ability to alter above relationship is the basic tenet of
anesthetic management in children with CHD
R
PQ
![Page 72: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/72.jpg)
ANESTHETIC MANAGEMENT
P manipulate with positive or negative
inotropic agents
Q hydration + preload and inotropes
However, the anesthesiologist’s principal focus
is an attempt to manipulate resistance, by dilators
and constrictors
![Page 73: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/73.jpg)
ANESTHETIC MANAGEMENT
• GENERAL CONSIDERATIONS
– De-air intravenous lines air bubble in a R-L shunt
can cross into systemic circulation and cause a
stroke
– L-R shunt air bubbles pass into lungs and are
absorbed
– Endocarditis prophylaxis
– Tracheal narrowing d/t subglottic stenosis or
associated vascular malformations
![Page 74: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/74.jpg)
ANESTHETIC MANAGEMENT
– Tracheal shortening or stenosis esp. in children
with trisomy 21
– Strokes from embolic phenomena in R-L shunts
and polycythemia
– Chronic hypoxemia compensated by polycythemia
→ ↑ O2 carrying capacity
– HCT ≥ 65% → ↑ blood viscosity → tissue hypoxia
& ↑ SVR & PVR → venous thrombosis → strokes
& cardiac ischemia
![Page 75: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/75.jpg)
ANESTHETIC MANAGEMENT
– Normal or low HCT D/T iron deficiency → less
deformable RBCs → ↑ blood viscosity
– Therefore adequate hydration & decrease RBC
mass if HCT > 65%
– Diuretics → hypochloremic, hypokalemic
metabolic alkalosis
![Page 76: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/76.jpg)
ANESTHETIC MANAGEMENT
ANESTHESIA INDUCTION
• Myocardial function preserved IV or
inhalational techniques suitable
• Severe cardiac defects IV induction
• Modify dosages in patients with severe
failure
![Page 77: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/77.jpg)
ANESTHESIC MANAGEMENT
ANESTHESIA MAINTENANCE
• Depends on preoperative status
• Response to induction & tolerance of
individual patient
• Midazolam 0.15-0.2 mg/IV for amnesia
![Page 78: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/78.jpg)
ANESTHETIC MANAGEMENT
• L - R SHUNTS :
• Continuous dilution in pulmonary
circulation may onset time of IV
agents
• Speed of induction with inhalation
agents not affected unless CO is
significantly reduced
• Degree of RV overload and/or failure
underappreciated – careful induction
![Page 79: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/79.jpg)
ANESTHETIC MANAGEMENT
• L-R SHUNTS :
– GOAL = SVR and ↑ PVR → L-R shunt
• PPV & PEEP increases PVR
• Ketamine increases SVR
• Inhalation agents decrease SVR
![Page 80: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/80.jpg)
ANESTHETIC MANAGEMENT
• R-L SHUNTS :
– GOAL : PBF by SVR and ↓ PVR
• PVR & ↓ SVR → ↓ PBF
– Hypoxemia/atelectasis/PEEP
– Acidosis/hypercapnia
– HCT
– Sympathetic stimulation & surgical stimulation
– Vasodilators & inhalation agents → ↓ SVR
![Page 81: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/81.jpg)
ANESTHETIC MANAGEMENT
• ↓ PVR & SVR → PBF
– Hyperoxia/Normal FRC
– Alkalosis/hypocapnia
– Low HCT
– Low mean airway pressure
– Blunted stress response
– Nitric oxide/ pulmonary vasodilators
– Vasoconstrictors & direct manipulation→ SVR
![Page 82: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/82.jpg)
ANESTHETIC MANAGEMENT
• R –L SHUNTS :
– Continue PE1 infusions
– Adequate hydration esp. if HCT > 50%
– Inhalation induction prolonged by limited
pulmonary blood flow
– IV induction times are more rapid d/t bypassing
pulmonary circulation dilution
– PEEP and PPV increase PVR
![Page 83: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/83.jpg)
ANESTHETIC MANAGEMENT
• COMPLEX SHUNTS :
• Manipulating PVR or SVR to PBF will:
• Not improve oxygenation
• Worsen biventricular failure
• Steal circulation from aorta and cause
coronary ischemia
• Maintain “status” quo with high dose opioids
that do not significantly affect heart rate,
contractibility, or resistance is recommended
![Page 84: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/84.jpg)
ANESTHETIC MANAGEMENT
• COMPLEX SHUNTS :
– Short procedures slow gradual induction with low
dose Halothane least effect on +ve chronotropy &
SVR
– Nitrous Oxide limits FiO2 & helps prevent
coronary steal & ↓ Halothane requirements
![Page 85: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/85.jpg)
ANESTHETIC MANAGEMENT
• OBSTRUCTIVE LESIONS
• Lesions with > 50 mmHg pressure gradient +
CHF opioid technique
• Optimize preload improves flow beyond
lesion
• Avoid tachycardia ↑ myocardial demand & ↓
flow beyond obstruction
• Inhalation agents -ve inotropy & decrease
SVR worsens gradient & flow past obstruction
![Page 86: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/86.jpg)
REGIONAL ANESTHESIA &ANALGESIA
• CONSIDERATIONS
– Coarctation of aorta dilated tortuous intercostal
collateral arteries risk for arterial puncture
and absorption of local anesthetic during
intercostal blockade
– Lungs may absorb up to 80% of local anesthetic on
first passage. Therefore risk of local anesthetic
toxicity in R-L shunts
![Page 87: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/87.jpg)
• Central axis blockade may cause
vasodilation which can:i. Be hazardous in patients with significant AS or
left-sided obstructive lesions
ii. Cause oxyhemoglobin saturation in R-L shunts
iii. Improve microcirculation flow and venous
thrombosis in patients with polycythemia
• Children with chronic cyanosis are at risk
for coagulation abnormalities
REGIONAL ANESTHESIA &ANALGESIA
![Page 88: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/88.jpg)
POSTOPERATIVE MANAGEMENT
• Children with CHD are very susceptible to:i. Deleterious effects of hypoventilation
ii. Mild decreases in oxyhemoglobin saturation
Therefore, give supplemental O2 and
maintain patent airway
• In patients with single ventricle titrate SaO2
to 85%. Higher oxygen saturations can
PVR PBF systemic blood flow
![Page 89: Anesthesia for children with Congenital Heart Disease](https://reader034.vdocuments.us/reader034/viewer/2022042601/5550514db4c90574428b45cf/html5/thumbnails/89.jpg)
• Pain catecholamines which can affect
vascular resistance and shunt direction
• Anticipate conduction disturbances in septal
defects
• Pain infundibular spasm in TOF
RVOT obstruction cyanosis, hypoxia,
syncope, seizures, acidosis and death
POSTOPERATIVE MANAGEMENT